EW

As of 2026-09-11, EW scores 45out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. EW trades at $86.77, 34% above the band ceiling.

EW scores 45 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 45. Its strongest factor is value at 60 (solid), where it screens cheap on the model's valuation inputs, followed by sentiment at 56. The weakest is momentum at 36, where price trend is the soft spot. Among Healthcare stocks it ranks in roughly the top 35% of the Healthcare names the model scores.

On valuation, EW is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 49. Same-sector names the model rates nearby include HALO, HNGE, THC.

This is a descriptive factor read on EW, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where EW sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for EW runs $49.98–$64.92. Current price $86.77 sits 34% above the band ceiling. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-11.